Strides Pharma Science has acquired a majority stake in Swiss generics firm Fairmed Healthcare in a move to bolster its presence in central Europe. The acquisition marks the latest in a string of transactions by the Indian firm.
Strides has acquired a majority stake in Swiss generics company Fairmed Healthcare in a move that will ramp up its fast-expanding “other regulated markets business” and provide the Indian drugmaker with a strong foothold in continental Europe.
Strides’ step-down subsidiary, Singapore-based Strides Pharma Global Pte Ltd, will hold 70% of Fairmed, which has a portfolio of generics...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
